National Diabetes Obesity and Cholesterol Foundation
10
3
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
To Compare People With T2DM Who Have Double Hump Versus Who do Not Have Double Hump
Role: collaborator
Comparison of Micro- and Macrovascular Disease(s) in People With T2D, Who Have Moderate to Severe Acanthosis Nigricans vs. Those Who do Not Have Acanthosis Nigricans
Role: collaborator
To Identify Anytime Hyperglycaemia in Subjects With Normoglycaemia and Prediabetes
Role: collaborator
Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content in Patients of Type 2 Diabetes Mellitus
Role: collaborator
Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis
Role: collaborator
Correlation of Xanthelasma With Atherosclerosis, Hepatic Fat and Fibrosis
Role: collaborator
Use of AI in Cardiometabolic Risk Prediction in Asian Indians
Role: collaborator
Assessment of Hand Grip Strength Using Jamar Dynamometer
Role: collaborator
Pre-meal Load of Raw Almonds and Postprandial Hyperglycemia
Role: collaborator
Almonds and Cognitive Functions
Role: collaborator
All 10 trials loaded